Ownership history in Aberdeen Group plc · 8 quarters on record
This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 502,913 | +111,313 | +28.4% | 0.04% | $23.9M | — |
| 2025 Q2 | REDUCED | 391,600 | -15,100 | -3.7% | 0.04% | $20.9M | — |
| 2025 Q1 | ADDED | 406,700 | +136,918 | +50.8% | 0.03% | $16.5M | — |
| 2024 Q4 | ADDED | 269,782 | +146,424 | +118.7% | 0.01% | $7.5M | — |